期刊文献+

Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis 被引量:20

Protective effects of MCP-1 inhibitor on a rat model of severe acute pancreatitis
下载PDF
导出
摘要 BACKGROUND: Chemokines and their receptors play key roles in the pathogenesis of acute pancreatitis. This study aimed to establish a rat model of severe acute pancreatitis (SAP) for investigating monocyte chemotactic protein-1 (MCP-1) expression in the pathogenesis of the disease. We assessed the effects of the inhibitor of MCP-1, Bindarit, on SAP and explored the mechanisms underlying SAP. METHODS: Seventy-two Sprague-Dawley rats were randomly divided into a saline control group (group S), an SAP group (group P), and a Bindarit group (group T). The SAP model was induced by retrograde infusion of 4% sodium taurocholate into the bilio-pancreatic duct. Based on the SAP model, Bindarit was injected intraperitoneally in group T, and 0.5% methyl cellulose was injected intraperitoneally in groups S and P. In group S, saline was retrogradely infused into the bilpancreatic duct. Serum amylase levels and the histological changes in the pancreas were assessed at different time-points in each group. Expression of MCP-1 in serum was measured by enzyme-linked immunoadsorbent assay (ELISA). MCP-1 protein and mRNA expression levels were detected by immunohistochemistry, Western blotting, and semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: Serum amylase levels in groups P and T were higher than those in group S. Serum amylase levels were significantly lower in group T than in group P at 6 and 12 hours after operation. The levels of MCP-1 in serum at 6 and 12 hours after operation in group P were significantly higher than in group S, and significantly lower in group T than in group P at 6 and 12 hours after operation. The pathological damage in the pancreas was milder in group T than in group P. MCP-1 protein and mRNA expression levels in the pancreas were higher in groups P and T than in group S. These expression levels were positively correlated with the pathological damage of pancreatic tissues. The activity of MCP-1 in group T was significantly lower than in group P. CONCLUSION: MCP-1 may play important roles in the pathogenesis of SAP. The data suggest that Bindarit ameliorates SAP by inhibiting the activity of MCP-1 in vivo. (Hepatobiliary Pancreat Dis Int 2010; 9: 201-207) BACKGROUND: Chemokines and their receptors play key roles in the pathogenesis of acute pancreatitis. This study aimed to establish a rat model of severe acute pancreatitis (SAP) for investigating monocyte chemotactic protein-1 (MCP-1) expression in the pathogenesis of the disease. We assessed the effects of the inhibitor of MCP-1, Bindarit, on SAP and explored the mechanisms underlying SAP. METHODS: Seventy-two Sprague-Dawley rats were randomly divided into a saline control group (group S), an SAP group (group P), and a Bindarit group (group T). The SAP model was induced by retrograde infusion of 4% sodium taurocholate into the bilio-pancreatic duct. Based on the SAP model, Bindarit was injected intraperitoneally in group T, and 0.5% methyl cellulose was injected intraperitoneally in groups S and P. In group S, saline was retrogradely infused into the bilpancreatic duct. Serum amylase levels and the histological changes in the pancreas were assessed at different time-points in each group. Expression of MCP-1 in serum was measured by enzyme-linked immunoadsorbent assay (ELISA). MCP-1 protein and mRNA expression levels were detected by immunohistochemistry, Western blotting, and semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). RESULTS: Serum amylase levels in groups P and T were higher than those in group S. Serum amylase levels were significantly lower in group T than in group P at 6 and 12 hours after operation. The levels of MCP-1 in serum at 6 and 12 hours after operation in group P were significantly higher than in group S, and significantly lower in group T than in group P at 6 and 12 hours after operation. The pathological damage in the pancreas was milder in group T than in group P. MCP-1 protein and mRNA expression levels in the pancreas were higher in groups P and T than in group S. These expression levels were positively correlated with the pathological damage of pancreatic tissues. The activity of MCP-1 in group T was significantly lower than in group P. CONCLUSION: MCP-1 may play important roles in the pathogenesis of SAP. The data suggest that Bindarit ameliorates SAP by inhibiting the activity of MCP-1 in vivo. (Hepatobiliary Pancreat Dis Int 2010; 9: 201-207)
机构地区 Nantong Univ
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2010年第2期201-207,共7页 国际肝胆胰疾病杂志(英文版)
基金 supported by grants from the social Burteall Foundation of Nantong(S5054)
关键词 severe acute pancreatitis monocyte chemotactic protein-1 Bindarit PATHOGENESIS severe acute pancreatitis monocyte chemotactic protein-1 Bindarit pathogenesis
  • 相关文献

参考文献24

  • 1A. Guglielmotti,E. D’Onofrio,I. Coletta,L. Aquilini,C. Milanese,M. Pinza.Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-α production[J]. Inflammation Research . 2002 (5)
  • 2Guglielmotti A,Aquilini L,D‘Onofrio E,Rosignoli MT,Milanese C,Pinza M.Bindarit prolongs survival and reduces renal damage in NZB/W lupus mice. Clinical and Experimental Rheumatology . 1998
  • 3Bhatia M,Hegde A.Treatment withantileukinate,a CXCR2 chemokinereceptor antagonist,protects mice against acute pancreatitis andassociatedlunginjury. Regulatory Peptides . 2007
  • 4Sun J,Bhatia M.Blockade of neurokinin-1receptor attenuates CC and CXC chemokine production in experimental acute pancreatitis and associated lung injury. American Journal of Physiology-gastrointestinal and Liver Physiology . 2007
  • 5M Inoue,Y Ino,J Gibo,T Ito,T Hisano,Y Arita.The role of monocyte chemoattractant protein-1 in experimental chronic pancreatitis model induced by dibutyltin dichloride in rats. Pancreas . 2002
  • 6Sironi M,Guglielmotti A,Polentarutti N,et al.A small synthetic molecule capable of preferentially inhibiting the production of the CC chemokine monocyte chemotactic protein-1. European Cytokine Network . 1999
  • 7Bhatia,M,Ramnath,RD,Chevali,L,Guglielmotti,A.Treatment with bindarit, a blocker of MCP-1 synthesis, protects mice against acute pancreatitis. American Journal of Physiology Gastrointestinal and Liver Physiology . 2005
  • 8Bhatia,M.,Brady,M.,Kang,Y.K.,Costello,E.,Newton,D.J.,Christmas,S.E.MCP-1 but not CINC synthesis is increased in rat pancreatic acini in response to cerulein hyperstimulation. American Journal of Physiology Gastrointestinal and Liver Physiology . 2002
  • 9AW Bossink,L Paemen,PM Jansen,CE Hack,LG Thijs,J Damme.Plasma levels of the chemokines monocyte chemotactic proteins-1 and -2 are elevated in human sepsis. Blood . 1995
  • 10Jansen,PM,Van,Damme,J,Put,W,de,Jong,IW,Jr.,Taylor,FB,Hack,CE.Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons. The Journal of Infectious Diseases . 1995

共引文献5

同被引文献117

引证文献20

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部